Guardant Health, Inc. (GH)
USD 32.36
(-7.12%)
USD 32.36
(-7.12%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -479.44 Million USD | 26.76% |
| 2022 | -654.58 Million USD | -70.12% |
| 2021 | -384.77 Million USD | -56.23% |
| 2020 | -246.28 Million USD | -262.98% |
| 2019 | -67.85 Million USD | 20.23% |
| 2018 | -85.06 Million USD | -2.21% |
| 2017 | -83.22 Million USD | -80.37% |
| 2016 | -46.13 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -102.62 Million USD | 10.75% |
| 2024 Q1 | -114.98 Million USD | 38.52% |
| 2023 Q3 | -86.1 Million USD | -18.32% |
| 2023 FY | -479.44 Million USD | 26.76% |
| 2023 Q2 | -72.77 Million USD | 45.5% |
| 2023 Q1 | -133.53 Million USD | 4.57% |
| 2023 Q4 | -187.04 Million USD | -117.23% |
| 2022 Q1 | -123.22 Million USD | -35.55% |
| 2022 FY | -654.58 Million USD | -70.12% |
| 2022 Q4 | -139.93 Million USD | 13.62% |
| 2022 Q3 | -161.99 Million USD | 29.39% |
| 2022 Q2 | -229.43 Million USD | -86.18% |
| 2021 FY | -384.77 Million USD | -56.23% |
| 2021 Q4 | -90.91 Million USD | 15.45% |
| 2021 Q3 | -107.52 Million USD | -10.2% |
| 2021 Q2 | -97.57 Million USD | 11.02% |
| 2021 Q1 | -109.65 Million USD | -16.97% |
| 2020 Q4 | -93.74 Million USD | -20.7% |
| 2020 Q3 | -77.67 Million USD | -42.15% |
| 2020 Q2 | -54.63 Million USD | -97.05% |
| 2020 Q1 | -27.72 Million USD | -9.99% |
| 2020 FY | -246.28 Million USD | -262.98% |
| 2019 Q1 | -26.05 Million USD | -3.7% |
| 2019 Q4 | -25.21 Million USD | -97.11% |
| 2019 Q3 | -12.79 Million USD | -10.26% |
| 2019 FY | -67.85 Million USD | 20.23% |
| 2019 Q2 | -11.6 Million USD | 55.47% |
| 2018 Q4 | -25.12 Million USD | -2.71% |
| 2018 Q2 | -21.63 Million USD | -56.31% |
| 2018 Q1 | -13.84 Million USD | 8.07% |
| 2018 FY | -85.06 Million USD | -2.21% |
| 2018 Q3 | -24.45 Million USD | -13.03% |
| 2017 Q1 | -20.31 Million USD | 0.0% |
| 2017 FY | -83.22 Million USD | -80.37% |
| 2017 Q3 | -28.59 Million USD | -21.39% |
| 2017 Q2 | -23.55 Million USD | -15.94% |
| 2017 Q4 | -15.06 Million USD | 47.32% |
| 2016 FY | -46.13 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Bionano Genomics, Inc. | -232.49 Million USD | -106.221% |
| Prenetics Global Limited | -62.72 Million USD | -664.38% |
| Star Equity Holdings, Inc. | -1.54 Million USD | -30872.158% |
| CareDx, Inc | -190.28 Million USD | -151.965% |
| Exact Sciences Corporation | -204.14 Million USD | -134.852% |
| Exagen Inc. | -23.68 Million USD | -1923.931% |
| Inotiv, Inc. | -105.14 Million USD | -356.01% |
| Biodesix, Inc. | -52.14 Million USD | -819.436% |
| BioNexus Gene Lab Corp. | -2.62 Million USD | -18136.636% |
| Precipio, Inc. | -5.85 Million USD | -8091.509% |
| iSpecimen Inc. | -11.09 Million USD | -4219.56% |
| Natera, Inc. | -434.8 Million USD | -10.269% |
| Aspira Women's Health Inc. | -16.69 Million USD | -2772.672% |
| Standard BioTools Inc. | -74.65 Million USD | -542.211% |
| 23andMe Holding Co. | -666.7 Million USD | 28.087% |
| Castle Biosciences, Inc. | -57.46 Million USD | -734.318% |
| Personalis, Inc. | -108.29 Million USD | -342.721% |
| Aclaris Therapeutics, Inc. | -88.48 Million USD | -441.867% |
| Applied DNA Sciences, Inc. | -9.94 Million USD | -4720.008% |
| OpGen, Inc. | -32.66 Million USD | -1367.617% |
| T2 Biosystems, Inc. | -50.07 Million USD | -857.424% |
| Myriad Genetics, Inc. | -112 Million USD | -328.079% |
| ICON Public Limited Company | 612.33 Million USD | 178.298% |
| NeoGenomics, Inc. | -87.96 Million USD | -445.027% |
| Star Equity Holdings, Inc. | -1.54 Million USD | -30872.158% |
| IDEXX Laboratories, Inc. | 845.04 Million USD | 156.737% |
| RadNet, Inc. | 3.04 Million USD | 15850.624% |
| MDxHealth SA | -43.1 Million USD | -1012.411% |
| Psychemedics Corporation | -4.15 Million USD | -11441.863% |
| Illumina, Inc. | -1.16 Billion USD | 58.704% |
| Check-Cap Ltd. | -17.56 Million USD | -2629.104% |
| Twist Bioscience Corporation | -208.72 Million USD | -129.703% |
| DarioHealth Corp. | -59.42 Million USD | -706.786% |
| Fulgent Genetics, Inc. | -167.82 Million USD | -185.684% |
| Sera Prognostics, Inc. | -36.24 Million USD | -1222.91% |
| ENDRA Life Sciences Inc. | -10.06 Million USD | -4665.776% |
| OPKO Health, Inc. | -188.86 Million USD | -153.861% |
| Medpace Holdings, Inc. | 282.81 Million USD | 269.53% |
| Neogen Corporation | -9.42 Million USD | -4989.152% |
| Intelligent Bio Solutions Inc. | -10.15 Million USD | -4620.492% |
| Prenetics Global Limited | -62.72 Million USD | -664.38% |
| Mainz Biomed B.V. | -26.29 Million USD | -1723.296% |
| bioAffinity Technologies, Inc. | -7.93 Million USD | -5940.675% |
| Trinity Biotech plc | -24.01 Million USD | -1896.207% |
| Neuronetics, Inc. | -30.18 Million USD | -1488.158% |
| Sotera Health Company | 51.37 Million USD | 1033.216% |
| bioAffinity Technologies, Inc. | -7.93 Million USD | -5940.675% |